Senyo App for Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What safety data exists for the Senyo App for Addiction?
There is no specific safety data available for the Senyo App for Addiction, but a systematic review of mobile health applications for addiction found that many apps are designed to inform users about risks and help manage cravings, suggesting a focus on user safety. However, more robust and long-term studies are needed to fully understand their safety and effectiveness.12345
How does the Senyo App treatment for addiction differ from other treatments?
The Senyo App treatment for addiction is unique because it leverages mobile health technology to improve access to care and manage cravings, which can help prevent relapse. Unlike traditional treatments, it offers a convenient, smartphone-based approach that can be used alongside standard treatments to enhance effectiveness.36789
What data supports the effectiveness of the Senyo App treatment for addiction?
Who Is on the Research Team?
Tyler Oesterle
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with Substance Use Disorder (SUD) who are patients at Mayo primary care clinics. The study aims to understand how a digital tool can help in their treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Waitlist
Subjects randomized to the waitlist group will serve as a control group and receive intervention after 12 weeks on the waitlist
Intervention
Subjects randomized to the Senyo group will begin receiving intervention immediately
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Senyo App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator